Patrys Ltd has released a press release.
Preliminary PAT-DX1 pharmacokinetics
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Patrys
- China and Japan both grant patents for Deoxymab 3E10
- PAT-DX1 Targets and Kills Brain Cancer Stem Cells
- Patrys Increases Capital Raising to $4.6 million
- New Pre-Clinical Collaboration on PAT-DX1
- Patrys Completes $3.5M Placement
Later from Patrys
- Appendix 4C - Quarterly - 30 June 2018
- Patent Granted for Pre-clinical IgM Candidate PAT-LM1
- Appendix 4E and 2018 Annual Report
- Patrys and WEHI Awarded Grant
- PAT-DX1 Clinical Target Indications Confirmed
Follow Patrys into a list and get an email when it puts out news.
Follow Patrys